/

Empresas

AO

No verificado

AOP Health US, LLC

Sobre qué escribimos

FarmacéuticaFinanzasHigiene alimentariaIndustriaMultimedia

4 Comunicados de prensa

Ver todos los comunicados de prensa

28/04/2026

AOP Health US Marks First Patient Treated with Rapiblyk® in the United States, Expanding Access to Critical Care Innovation Nationwide

Fuente

AOP Health US, LLC

Editor

1.00

0

15/04/2026

Multimedia

Industria

Cardiología

Higiene alimentaria

Asociaciones/Profesionales

Salud

Sanidad

Farmacéutica

Ciencia

Medicina - Varios

Finanzas

AOP Health US LLC: RAPIBLYK® (landiolol) Approved by FDA for Use in Pediatric Patients with Supraventricular Tachycardia

Fuente

AOP Health US, LLC

Editor

1.00

0

10/02/2026

AOP Health US, LLC Awarded Pharmaceutical Agreement With Premier, Inc.

Fuente

AOP Health US, LLC

Editor

1.00

0

05/02/2026

AOP Health's Rapiblyk® (landiolol) Now Accessible via Vizient® Contract

Fuente

AOP Health US, LLC

Editor

1.00

0

Seguidores

0

Compatibilidad

0